OCUL | Ocular Therapeutix Inc
Category: Consumer goods
Quick infos Headquarters: Bedford, Massachusetts, United States Trade prices Volume: Market Cap: 295.5M Prev closed: Open: 4.92 High: 4.99 Low: 4.66 52 week low: 4.66 52 week high: 19.84 Dividends: No Dividends Next ER: May 9, 2022 After Market Closes
Earnings History Date EPS / Forecast Revenue / Forecast August 9, 2022 May 9, 2022 -0.22 / -0.23513.19M / 14.94MFebruary 28, 2022 -0.05 / -0.23412.31M / 13.94MNovember 8, 2021 0.03 / -0.2612.15M / 12.45MAugust 9, 2021 -0.11 / -0.2111.72M / 10.83MBeat! view more
Historical Data Date Price Open High Low Vol Change ER May 9, 2022 3.26 3.46 3.46
3.18
738.29K -6.05% May 6, 2022 3.47 3.83 3.83
3.47
592.79K -9.87% May 5, 2022 3.85 4.03 4.17
3.79
652.67K -6.33% May 4, 2022 4.11 4.07 4.11
3.78
1.06M 1.23% May 3, 2022 4.06 3.92 4.09
3.87
581.97K 2.01% May 2, 2022 3.98 3.57 3.99
3.51
602.53K 11.48% Apr 29, 2022 3.57 3.74 3.86
3.54
519.58K -5.56% Apr 28, 2022 3.78 3.76 3.86
3.58
518.72K 1.34% Apr 27, 2022 3.73 3.91 3.91
3.70
628.11K -5.81% Apr 26, 2022 3.96 3.85 4.03
3.81
581.66K 1.28% view more
NASDAQ - Nasdaq Stock Market
News
Mid-Morning Market Update: Markets Mixed; American Express Earnings Beat Views finance.yahoo.com Apr 6, 2022 10:08 am
Ocular Therapeutix Announces Topline Results for Phase 2 Clinical Trial of OTX-CSI for the Treatment of Dry Eye Disease Did Not Meet Primary Endpoint finance.yahoo.com Apr 6, 2022 8:00 am
Ocular Therapeutix (NASDAQ:OCUL) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway finance.yahoo.com Apr 6, 2022 7:44 am Ocular Therapeutix GAAP EPS of -$0.23 in-line, revenue of $12.31M misses by $2.13M seekingalpha.com Mar 1, 2022 5:03 am Ocular Therapeutix Q4 2021 Earnings Preview seekingalpha.com Feb 28, 2022 6:35 am Ocular Therapeutix owner buys 50,000 shares worth ~$300K seekingalpha.com Jan 20, 2022 3:43 am 3 Small-Cap Stocks to Buy Now and Hold for the Long Haul fool.com Nov 20, 2021 6:09 am
Ocular Therapeutix to Present at the Cowen 42nd Annual Healthcare Conference finance.yahoo.com Mar 4, 2022 8:00 am
Ocular Therapeutix (OCUL) Reports Q4 Loss, Lags Revenue Estimates finance.yahoo.com Feb 28, 2022 5:35 pm
Theravance Biopharma (TBPH) Reports Q4 Loss, Lags Revenue Estimates finance.yahoo.com Feb 23, 2022 6:05 pm
Ocular Therapeutix Announces Upcoming Presentation of Interim OTX-TKI Phase 1 Clinical Trial Data at Angiogenesis, Exudation, and Degeneration 2022 Meeting and OTX-TIC Phase 1 Clinical Trial at Glaucoma 360 finance.yahoo.com Feb 11, 2022 8:00 am AffaMed Therapeutics begins dosing in China trial of DEXTENZA to treat ocular inflammation seekingalpha.com Jan 19, 2022 3:51 am
Hikari Power Ltd Buys Alphabet Inc, Vanguard Health Care ETF, Bristol-Myers Squibb Co, Sells ... finance.yahoo.com Jan 12, 2022 9:38 am Ocular Therapeutix trades high on director acquiring 60.9K shares seekingalpha.com Dec 10, 2021 1:42 am Ocular Therapeutix reports positive OTX-DED data in mid-stage dry eye disease study seekingalpha.com Dec 6, 2021 10:07 pm
Ocular Therapeutix Stock Gains As Court Invalidates Drug Delivery Patent From Mati finance.yahoo.com Nov 9, 2021 1:17 pm Ocular Therapeutix EPS beats by $0.04, misses on revenue seekingalpha.com Nov 9, 2021 5:02 am
Ocular Therapeutix (OCUL) Reports Q3 Loss, Tops Revenue Estimates finance.yahoo.com Nov 8, 2021 7:35 pm Ocular Therapeutix Q3 2021 Earnings Preview seekingalpha.com Nov 8, 2021 5:35 am
Could The Ocular Therapeutix, Inc. (NASDAQ:OCUL) Ownership Structure Tell Us Something Useful? finance.yahoo.com Nov 5, 2021 11:44 am This company doesn't provide a dividend.
Talk about Ocular Therapeutix Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus BUY 100 HOLD 0 SELL 0
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.
Take advantage of price swings in strongly trending securities and pump up your portfolio!